Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 10, 2010
Discrete choice modeling for the quantification of health states: the case of the EQ-5D
Elly A Stolk, Mark Oppe, Luciana Scalone, et al.
The Patient
|
February 16, 2022
Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain
Anabel Estévez-Carrillo, Sarah Dewilde, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
To What Extent Do Patient Preferences Differ From General Population Preferences?
Kristina Ludwig, Juan M Ramos-Goñi, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 1, 2013
Introducing the composite time trade-off: a test of feasibility and face validity
Bas M F Janssen, Mark Oppe, Matthijs M Versteegh, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 5, 2013
Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?
Feng Xie, Eleanor Pullenayegum, Kathryn Gaebel, et al.
Pharmacoeconomics
|
April 17, 2016
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
Mark Oppe, Kim Rand-Hendriksen, Koonal Shah, et al.
The Patient
|
March 15, 2025
How do Design Characteristics Affect Respondent Engagement? Assessing Attribute Non-attendance in Discrete Choice Experiments Valuing the EQ-5D-5L
Peiwen Jiang, Deborah Street, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 12, 2019
Toward a Smaller Design for EQ-5D-5L Valuation Studies
Zhihao Yang, Nan Luo, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 2, 2022
Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data
Juan M Ramos-Goñi, Mark Oppe, Anabel Estévez-Carrillo, et al.
Pharmacoeconomics
|
June 6, 2013
A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes
Pepijn Vemer, Maiwenn J Al, Mark Oppe, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 10, 2010
Discrete choice modeling for the quantification of health states: the case of the EQ-5D
Elly A Stolk, Mark Oppe, Luciana Scalone, et al.
The Patient
|
February 16, 2022
Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain
Anabel Estévez-Carrillo, Sarah Dewilde, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
To What Extent Do Patient Preferences Differ From General Population Preferences?
Kristina Ludwig, Juan M Ramos-Goñi, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 1, 2013
Introducing the composite time trade-off: a test of feasibility and face validity
Bas M F Janssen, Mark Oppe, Matthijs M Versteegh, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 5, 2013
Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?
Feng Xie, Eleanor Pullenayegum, Kathryn Gaebel, et al.
Pharmacoeconomics
|
April 17, 2016
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
Mark Oppe, Kim Rand-Hendriksen, Koonal Shah, et al.
The Patient
|
March 15, 2025
How do Design Characteristics Affect Respondent Engagement? Assessing Attribute Non-attendance in Discrete Choice Experiments Valuing the EQ-5D-5L
Peiwen Jiang, Deborah Street, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 12, 2019
Toward a Smaller Design for EQ-5D-5L Valuation Studies
Zhihao Yang, Nan Luo, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 2, 2022
Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data
Juan M Ramos-Goñi, Mark Oppe, Anabel Estévez-Carrillo, et al.
Pharmacoeconomics
|
June 6, 2013
A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes
Pepijn Vemer, Maiwenn J Al, Mark Oppe, et al.
Page
of 6